Funding for this research was provided by:
National Key R&D Program of China (2016YFC0902400)
the State Key Program of National Natural Science of China (81530077)
the National Natural Science Foundation of China (81602543, 81672839, 81372317, 81472676, 81572823, 81772551)
the Projects from the Shanghai Science and Technology Commission (14DZ1940300, 14411970200)
“Strategic Priority Research Program” of the Chinese Academy of Sciences (XDA12020103, XDA12020105)
Received: 20 November 2017
Accepted: 30 April 2018
First Online: 9 May 2018
Ethics approval and consent to participate
: This study was approved by the ethics board at the Liver Cancer Institute of Zhongshan Hospital, Fudan University. All participants provided written informed consent for their material to be turned into patient-derived xenograft.All mouse experiments have been regulate daccording to the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the Institutional Animal Care and Treatment Committee of Fudan University, and have been performed in accordance with the Home Office license awarded to J.F.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.